Mike Scialom talks to Sir Hugh Pelham about why pledge from the MRC LMB and AstraZeneca could mean good news for Cambridge. This article is no longer available from the source website: Cambridge News 20 May 2014
Hugh Pelham discusses research collaboration between LMB and AstraZeneca in more depth
Research collaboration between LMB and AstraZeneca
The Reuters news agency reports further detail of a joint research fund between the MRC Laboratory of Molecular Biology and AstraZeneca. More…
Jason Chin discusses synthetic biology on Guardian Science Weekly Podcast
In this Science Weekly podcast, Jason Chin, programme leader at MRC LMB, is interviewed by Guardian science correspondent Ian Sample. Jason explains his own work in the field and why synthetic forms of DNA are crucial both for furthering our understanding of fundamental biology and for creating a new generation of tools for medical science. More…
Max Perutz: science communicator
Max Perutz, the Austrian-born molecular biologist who founded the MRC Laboratory of Molecular Biology in 1962, won the Nobel Prize for his work deciphering the structure of the blood protein haemoglobin. But he was also a passionate writer and speaker committed to revealing the intricacies of science to new audiences. As we launch the 2014 Max Perutz Science Writing Award, Katherine Nightingale looks back on his forays into the world of words. More…
Speaking at the LMB, George Osborne backs science funding for Cambridge
The Chancellor George Osborne visited the LMB on 25th April to announce that the science budget would continue to back research in Cambridge, saying that scientific achievement in Cambridge was “one of Britain’s greatest and most exciting success stories”. This article is no longer available from the source website: Cambridge News 25 April 2014
LMB’s Melina Schuh interviewed in the Journal of Cell Biology
Melina Schuh from the LMB’s Cell Biology division discusses her work on oocytes in an interview for the Journal of Cell Biology. More…